We are live on ! Find out more
KURA icon

Kura Oncology
KURA

107 hedge funds and large institutions have $541M invested in Kura Oncology in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 40 increasing their positions, 30 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 12

33% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 30

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

22% more capital invested

Capital invested by funds: $442M → $541M (+$98.8M)

17.9% more ownership

Funds ownership: 70.68% → 88.57% (+18%)

9% more funds holding

Funds holding: 98 → 107 (+9)

92% less call options, than puts

Call options by funds: $198K | Put options by funds: $2.35M

Holders
107
Holders Change
+9
Holders Change %
+9.18%
% of All Funds
2.45%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
22
Increased
40
Reduced
30
Closed
12
Calls
$198K
Puts
$2.35M
Net Calls
-$2.15M
Net Calls Change
-$2.12M

Top Buyers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
+$25.2M
2
EAM
Eagle Asset Management
Florida
+$23.2M
3
CTA
Carillon Tower Advisers
Florida
+$15.7M
4
BI
BVF Inc
California
+$11.9M
5
BlackRock
BlackRock
New York
+$6.89M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$18.1M
2
PHS
PFM Health Sciences
California
-$4.27M
3
AG
Artal Group
Luxembourg
-$1.88M
4
EI
EAM Investors
California
-$1.47M
5
EGI
EAM Global Investors
California
-$992K
Name Holding Trade Value Shares
Change 		Change in
Stake
Invesco
26
Invesco
Georgia
$3.17M +$1.62M +95,844 +123%
SI
27
Sofinnova Investments
California
$3.06M +$2.84M +167,900 New
Point72 Asset Management
28
Point72 Asset Management
Connecticut
$2.41M +$2.24M +132,546 New
CCP
29
Clough Capital Partners
Massachusetts
$2.3M -$713K -42,100 -25%
Walleye Trading
30
Walleye Trading
New York
$2.25M +$498K +29,397 +31%
TAM
31
Tiverton Asset Management
Delaware
$2.19M -$316K -18,631 -13%
MA
32
Minerva Advisors
Pennsylvania
$1.88M -$34 -2 -0%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$1.86M +$323K +19,072 +23%
KCM
34
Kennedy Capital Management
Missouri
$1.77M +$1.65M +97,294 New
CIA
35
Capital Impact Advisors
Massachusetts
$1.67M +$281K +16,600 +21%
Deutsche Bank
36
Deutsche Bank
Germany
$1.6M -$192K -11,324 -11%
SSA
37
Schonfeld Strategic Advisors
New York
$1.53M -$28.4K -1,676 -2%
Morgan Stanley
38
Morgan Stanley
New York
$1.46M +$325K +19,211 +31%
AGA
39
Altrinsic Global Advisors
Connecticut
$1.46M – – –
CH
40
CVI Holdings
Delaware
$1.39M +$1.29M +76,200 New
Hudson Bay Capital Management
41
Hudson Bay Capital Management
Connecticut
$1.27M +$339K +20,000 +40%
UOC
42
UBS O'Connor
Illinois
$1.2M -$69.4K -4,100 -6%
Charles Schwab
43
Charles Schwab
California
$1.04M +$203K +11,961 +26%
CM
44
Crestline Management
Texas
$894K +$832K +49,121 New
AA
45
ALPS Advisors
Colorado
$881K +$133K +7,874 +19%
TCIM
46
TIAA CREF Investment Management
New York
$862K -$8.71K -514 -1%
VEA
47
Virtus ETF Advisers
New York
$794K -$197K -11,650 -21%
TA
48
Teachers Advisors
New York
$773K +$117K +6,927 +19%
Swiss National Bank
49
Swiss National Bank
Switzerland
$768K +$715K +42,200 New
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$692K +$89.1K +5,263 +16%
1
2
3 4 5

KURA Hedge Fund Activity: Q2 2018 in Review

107 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q2 2018, worth a combined $541M — up 22% from $442M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new KURA positions and 12 closed out — a net gain of 10 holders — while 40 added to existing stakes and 30 trimmed.

The largest buyer was Victory Capital Management, opening a new position worth an estimated $25.2M. The largest seller was Fidelity Investments, cutting an estimated $18.1M.

  • 107 institutional investors held Kura Oncology (KURA) as of Q2 2018, up from 98 in Q1 2018.
  • Funds reported $541M of Kura Oncology stock for Q2 2018, up 22% quarter-over-quarter.
  • 22 funds opened new Kura Oncology positions in Q2 2018 and 12 closed out, a net change of +10 holders.
  • The largest Kura Oncology buyer in Q2 2018 was Victory Capital Management, an estimated $25.2M added.
  • The largest Kura Oncology seller in Q2 2018 was Fidelity Investments, an estimated $18.1M sold.

Based on aggregated 13F filings for Q2 2018.